3Dバイオプリンティング人体組織市場レポート：2031年までの動向、予測、競合分析

世界の3Dバイオプリンティング人体組織市場の将来は、組織工学、美容整形、薬物試験・開発、食品検査市場に機会があり、有望視されています。世界の3Dバイオプリンティング人体組織市場は、2025年から2031年までのCAGRが7.8%で、2031年までに推定37億米ドルに達すると予想されています。この市場の主な促進要因は、免疫細胞療法への傾斜の高まり、技術の進歩、カスタマイズされた3Dプリンティング、組織工学、臓器置換に対する需要の高まりです。

• Lucintelの予測では、用途別では、臨床試験用途での採用が増加していることから、医薬品試験・開発分野が予測期間中に最も高い成長を遂げる見込みです。
• 地域別では、政府の研究開発費の増加により北米が予測期間中最大の地域であり続ける。

3Dバイオプリンティング人体組織市場の戦略的成長機会

3Dバイオプリンティング人体組織市場は、さまざまな用途で戦略的成長機会を提供しています。これらの機会は、技術の進歩、個別化医療に対する需要の増加、研究および治療用途の拡大によってもたらされます。

• 創薬と検査：バイオプリンティング組織は、創薬と検査でますます使用されるようになっています。このアプリケーションは、薬剤の有効性と安全性を評価するための人体組織の正確なモデルを作成する機会を提供し、動物実験への依存を低減します。
• 再生医療：再生医療におけるバイオプリンティング組織の可能性は大きいです。損傷した臓器や組織を修復したり置き換えたりするための組織構築物を開発する機会が存在し、様々な病状に対する新しい治療法を提供します。
• 個別化医療：個別化医療におけるバイオプリンティング組織の利用は拡大しています。個々の患者の遺伝子プロファイルや医療ニーズに合わせたカスタム・バイオプリンティング組織が開発され、より効果的で個別化された治療オプションが提供されています。
• 研究開発：研究開発におけるバイオプリンティング組織の市場は拡大しています。バイオプリンティングモデルは、疾病メカニズム、組織発達、細胞相互作用を研究するための貴重なツールであり、生物医学研究の革新を促進します。
• 臨床応用：バイオプリンティング技術の進歩は、臨床応用の機会を生み出しています。技術が成熟するにつれて、バイオプリンティングされた組織は、傷害や変性疾患の治療に直接臨床使用することが検討されています。

3Dバイオプリンティング人体組織市場の戦略的成長機会には、創薬、再生医療、個別化医療、研究開発、臨床応用への応用が含まれます。これらの機会は、ヘルスケアと研究の様々な側面を変革するバイオプリンティング組織の可能性の拡大を反映しています。

3Dバイオプリンティング人体組織市場の促進要因・課題

3Dバイオプリンティング人体組織市場は、技術進歩、経済要因、規制問題など、さまざまな市場促進要因・課題によって形成されています。これらの要因を理解することは、市場をナビゲートし、成長を達成するために極めて重要です。

3Dバイオプリンティング人体組織市場の促進要因は以下の通り：

• 技術の進歩：バイオプリンティング技術の革新は、バイオプリンティング組織の機能と応用を強化します。印刷技術、材料、設計ソフトウェアの進歩が市場の成長を促進し、可能性を広げます。
• 研究資金の増加：研究開発への投資拡大がバイオプリンティング組織の進歩を支えます。政府、民間、学術機関からの資金援助が技術革新を加速し、市場拡大を後押しします。
• 個別化医療の需要：個別化医療に対する需要の高まりが、カスタム・バイオプリンティング組織の必要性を煽っています。個別化治療や薬物検査には、個々の患者の特徴を忠実に模倣した組織が必要です。
• 再生医療の可能性：再生医療におけるバイオプリンティング組織の可能性は、関心と投資の原動力となっています。バイオプリンティングは、損傷した組織や臓器を修復したり置き換えたりするための新しいソリューションを提供します。
• 規制面のサポート：進化する規制の枠組みは、バイオプリンティング組織の商業化を促進します。更新されたガイドラインや基準は、承認プロセスを合理化し、市場の成長をサポートします。

3Dバイオプリンティング人体組織市場の課題は以下の通り：

• コスト高：バイオプリンティング技術と材料のコストが高いことが、普及の障壁となっています。コストの問題に対処することは、バイオプリンティング組織をより身近で手頃なものにするために不可欠です。
• 技術的限界：複雑な組織構造の実現や血管網の統合など、バイオプリンティングにおける現在の技術的限界は課題となっています。これらの限界を克服することは、この分野の発展にとって極めて重要です。
• 規制上のハードル：バイオプリンティングされた組織に対する規制要件を理解することは複雑です。市場に参入し、受け入れられるためには、安全性と有効性の基準を確実に遵守することが必要です。

3Dバイオプリンティング人体組織市場は、技術の進歩、研究資金の増加、個別化医療の需要、再生医療の可能性、規制当局の支援によって牽引されています。課題としては、高コスト、技術的限界、規制上のハードル、拡張性の問題、倫理的懸念などが挙げられます。これらの要因に対処することが、市場の成長と成功の鍵です。

目次

第1章 エグゼクティブサマリー

第2章 世界の3Dバイオプリンティング人体組織市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019-2024年）と予測（2025-2031年）
• 世界の3Dバイオプリンティング人体組織市場の動向（2019-2024）と予測（2025-2031）
• 用途別
  • 組織工学
  • 美容整形
  • 医薬品の試験と開発
  • 食品検査
  • その他

第4章 2019年から2031年までの地域別市場動向と予測分析

• 地域別：3Dバイオプリンティング人体組織の世界市場
• 北米の3Dバイオプリンティング人体組織市場
• 欧州の3Dバイオプリンティング人体組織市場
• アジア太平洋の3Dバイオプリンティング人体組織市場
• その他地域の3Dバイオプリンティング人体組織市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 用途別
  • 地域別
• 世界の3Dバイオプリンティング人体組織市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の3Dバイオプリンティング人体組織市場の生産能力拡大
  • 世界の3Dバイオプリンティング人体組織市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

The future of the global 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets. The global 3D bioprinted human tissue market is expected to reach an estimated $3.7 billion by 2031 with a CAGR of 7.8% from 2025 to 2031. The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

• Lucintel forecasts that, within the application category, the drug testing and development segment is expected to witness the highest growth over the forecast period due to its increasing adoption in clinical trial applications.
• In terms of regions, North America will remain the largest region over the forecast period due to rising government R&D spending.

Gain valuable insight for your business decision with our comprehensive 150+ page report.

Emerging Trends in the 3D Bioprinted Human Tissue Market

Emerging trends in the 3D bioprinted human tissue market reflect advancements in technology, applications, and material science. These trends are shaping the future of tissue engineering, offering new possibilities for research, medicine, and biotechnology.

• Enhanced Biomaterials: The development of new biomaterials with improved biocompatibility and functionality is accelerating. These materials enhance the structural integrity and performance of bioprinted tissues, making them more suitable for complex applications in regenerative medicine and research.
• Vascularization Techniques: Innovations in vascularization techniques are crucial for creating more functional bioprinted tissues. Advances in incorporating vascular networks within bioprinted constructs improve tissue survival and integration, bringing the field closer to fully functional organ replacements.
• Integration with AI and Machine Learning: The integration of AI and machine learning in bioprinting processes is improving precision and efficiency. These technologies help optimize design parameters, predict tissue behavior, and enhance overall bioprinting outcomes.
• Personalized Medicine Applications: There is a growing focus on using bioprinted tissues for personalized medicine. Custom bioprinted tissues tailored to individual patient needs are being developed for drug testing and therapeutic applications, offering more personalized treatment options.
• Regenerative Medicine Advancements: Advances in regenerative medicine are driving the demand for bioprinted tissues. The ability to create functional tissue constructs for repairing or replacing damaged tissues and organs is expanding the potential applications of 3D bioprinting.

Emerging trends such as enhanced biomaterials, vascularization techniques, AI integration, personalized medicine applications, and regenerative medicine advancements are reshaping the 3D bioprinted human tissue market. These trends are driving innovation and expanding possibilities for bioprinted tissues in research and clinical applications.

Recent Developments in the 3D Bioprinted Human Tissue Market

Recent developments in the 3D bioprinted human tissue market highlight technological advancements, improved materials, and expanded applications. These developments are advancing the capabilities of bioprinted tissues and their potential uses in research and medicine.

• Advanced Bioprinting Technologies: New bioprinting technologies enhance the resolution and complexity of bioprinted tissues. These advancements allow for the creation of more detailed and functional tissue models, improving their utility for research and therapeutic applications.
• Improved Biomaterial Formulations: Recent improvements in biomaterial formulations increase the viability and functionality of bioprinted tissues. Innovations in materials such as hydrogels and bio-inks enhance the structural integrity and biological performance of printed constructs.
• Functional Tissue Constructs: Progress in creating functional tissue constructs advances the field. Researchers are developing bioprinted tissues with complex structures and functionalities, such as organs and tissues with integrated vascular networks, for more realistic and useful models.
• Regulatory Advances: Recent regulatory developments support the commercialization of bioprinted tissues. Updated guidelines and frameworks help streamline approval processes for bioprinted products, facilitating their transition from research to clinical applications.
• Collaborative Research Initiatives: Increased collaboration between academia, industry, and healthcare institutions drives innovation in 3D bioprinting. These partnerships accelerate the development and application of bioprinted tissues, enhancing research capabilities and expanding market potential.

Key developments in the 3D bioprinted human tissue market include advancements in bioprinting technologies, improved biomaterial formulations, the creation of functional tissue constructs, regulatory advances, and collaborative research initiatives. These developments enhance the capabilities and applications of bioprinted tissues.

Strategic Growth Opportunities for 3D Bioprinted Human Tissue Market

The 3D bioprinted human tissue market offers strategic growth opportunities across various applications. These opportunities are driven by technological advancements, increasing demand for personalized medicine, and expanding research and therapeutic applications.

• Drug Discovery and Testing: Bioprinted tissues are increasingly used in drug discovery and testing. This application offers opportunities to create accurate models of human tissues for evaluating drug efficacy and safety, reducing the reliance on animal testing.
• Regenerative Medicine: The potential for bioprinted tissues in regenerative medicine is substantial. Opportunities exist in developing tissue constructs for repairing or replacing damaged organs and tissues, providing new treatments for various medical conditions.
• Personalized Medicine: The use of bioprinted tissues in personalized medicine is growing. Custom bioprinted tissues tailored to individual patients' genetic profiles and medical needs are being developed, providing more effective and personalized treatment options.
• Research and Development: The market for bioprinted tissues in research and development is expanding. Bioprinted models offer valuable tools for studying disease mechanisms, tissue development, and cellular interactions, driving innovation in biomedical research.
• Clinical Applications: Advances in bioprinting technology are creating opportunities for clinical applications. As the technology matures, bioprinted tissues are being explored for direct clinical use in treating injuries and degenerative diseases.

Strategic growth opportunities in the 3D bioprinted human tissue market include applications in drug discovery, regenerative medicine, personalized medicine, research and development, and clinical applications. These opportunities reflect the expanding potential of bioprinted tissues to transform various aspects of healthcare and research.

3D Bioprinted Human Tissue Market Driver and Challenges

The 3D bioprinted human tissue market is shaped by various drivers and challenges, including technological advancements, economic factors, and regulatory issues. Understanding these factors is crucial for navigating the market and achieving growth.

The factors responsible for driving the 3D bioprinted human tissue market include:

• Technological Advancements: Innovations in bioprinting technology enhance the capabilities and applications of bioprinted tissues. Advances in printing techniques, materials, and design software drive market growth and expand possibilities.
• Increased Research Funding: Growing investment in research and development supports the advancement of bioprinted tissues. Funding from government, private, and academic sources accelerates innovation and drives market expansion.
• Demand for Personalized Medicine: Rising demand for personalized medicine fuels the need for custom bioprinted tissues. Personalized treatments and drug testing require tissues that closely mimic individual patient characteristics.
• Regenerative Medicine Potential: The potential for bioprinted tissues in regenerative medicine drives interest and investment. Bioprinting offers new solutions for repairing or replacing damaged tissues and organs.
• Regulatory Support: Evolving regulatory frameworks facilitate the commercialization of bioprinted tissues. Updated guidelines and standards help streamline the approval process and support market growth.

Challenges in the 3D bioprinted human tissue market are:

• High Costs: The high costs of bioprinting technology and materials pose a barrier to widespread adoption. Addressing cost issues is essential for making bioprinted tissues more accessible and affordable.
• Technical Limitations: Current technical limitations in bioprinting, such as achieving complex tissue structures and integrating vascular networks, present challenges. Overcoming these limitations is crucial for advancing the field.
• Regulatory Hurdles: Navigating regulatory requirements for bioprinted tissues can be complex. Ensuring compliance with safety and efficacy standards is necessary for market entry and acceptance.

The 3D bioprinted human tissue market is driven by technological advancements, increased research funding, demand for personalized medicine, regenerative medicine potential, and regulatory support. Challenges include high costs, technical limitations, regulatory hurdles, scalability issues, and ethical concerns. Addressing these factors is key to market growth and success.

List of 3D Bioprinted Human Tissue Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies 3D bioprinted human tissue companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D bioprinted human tissue companies profiled in this report include-

• Organovo
• Stratasys
• 3D Systems
• SOLS Systems
• Youbionic

3D Bioprinted Human Tissue by Segment

The study includes a forecast for the global 3D bioprinted human tissue market by application and region.

3D Bioprinted Human Tissue Market by Application [Analysis by Value from 2019 to 2031]:

• Tissue Engineering
• Cosmetic Surgery
• Drug Testing and Development
• Food Testing
• Others

3D Bioprinted Human Tissue Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the 3D Bioprinted Human Tissue Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The following image highlights recent developments by major 3D bioprinted human tissue producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the United States, significant progress has been made in the development of complex tissue structures for drug testing and regenerative medicine. Companies are focusing on enhancing tissue vascularization and functionality, with breakthroughs in bioprinting organs and tissues that more accurately mimic human physiology.
• China: China is advancing in scaling up 3D bioprinting technologies, particularly in creating tissue models for medical research and testing. Government support and funding have accelerated advancements in bioprinting capabilities, to establish China as a leader in bioprinted tissue development.
• Germany: Germany has been progressing in 3D bioprinting with an emphasis on integrating advanced biomaterials and improving tissue engineering techniques. German research institutions are working on enhancing the precision and complexity of bioprinted tissues to support drug discovery and regenerative therapies.
• India: In India, the focus is on developing cost-effective bioprinting solutions and scaling up research capabilities. Indian institutions and startups are making progress in creating bioprinted tissues for research and medical applications, emphasizing affordability and accessibility for broader use.
• Japan: Japan is leading in the development of advanced bioprinting technologies and materials. Japanese researchers are focusing on bioprinting functional tissue constructs for regenerative medicine and exploring collaborations to integrate these technologies into clinical applications.

Features of the Global 3D Bioprinted Human Tissue Market

Market Size Estimates: 3D bioprinted human tissue market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: 3D bioprinted human tissue market size by application and region in terms of value ($B).

Regional Analysis: 3D bioprinted human tissue market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications and regions for the 3D bioprinted human tissue market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 3D bioprinted human tissue market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the 3D bioprinted human tissue market by application (tissue engineering, cosmetic surgery, drug testing and development, food testing, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global 3D Bioprinted Human Tissue Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global 3D Bioprinted Human Tissue Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global 3D Bioprinted Human Tissue Market by Application
  • 3.3.1: Tissue Engineering
  • 3.3.2: Cosmetic Surgery
  • 3.3.3: Drug Testing and Development
  • 3.3.4: Food Testing
  • 3.3.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global 3D Bioprinted Human Tissue Market by Region
• 4.2: North American 3D Bioprinted Human Tissue Market
  • 4.2.1: North American Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.3: European 3D Bioprinted Human Tissue Market
  • 4.3.1: European Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.4: APAC 3D Bioprinted Human Tissue Market
  • 4.4.1: APAC Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
• 4.5: ROW 3D Bioprinted Human Tissue Market
  • 4.5.1: ROW Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Application
  • 6.1.2: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Region
• 6.2: Emerging Trends in the Global 3D Bioprinted Human Tissue Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global 3D Bioprinted Human Tissue Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global 3D Bioprinted Human Tissue Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Organovo
• 7.2: Stratasys
• 7.3: 3D Systems
• 7.4: SOLS Systems
• 7.5: Youbionic